Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK

JF Guest, JP Clegg, AM Davie… - Current medical research …, 2005 - Taylor & Francis
Objective: To estimate the costs and consequences of using pamidronate compared to
zoledronic acid in the prophylactic management of skeletal morbidity among breast cancer …
被引用次数：15 相关文章

Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK

JF Guest, JP Clegg, AM Davie… - … Medical Research and …, 2005 - search.proquest.com
OBJECTIVE: To estimate the costs and consequences of using pamidronate compared to
zoledronic acid in the prophylactic management of skeletal morbidity among breast cancer …

Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK

JF Guest, JP Clegg, AM Davie… - … medical research and …, 2005 - pubmed.ncbi.nlm.nih.gov
Objective To estimate the costs and consequences of using pamidronate compared to
zoledronic acid in the prophylactic management of skeletal morbidity among breast cancer …

Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK.

JF Guest, JP Clegg, AM Davie… - … Medical Research and …, 2005 - europepmc.org
Costs and consequences of using pamidronate compared with zoledronic acid in the
management of breast cancer patients in the UK. - Abstract - Europe PMC Sign in | Create an …